(Post-pandemic Era)-Global NASH Drug Pipeline Market Segment Research Report 2022
- Published Date: 2022-04-19
- Report ID: 128078
- Pages: 175
-
Format:
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global NASH Drug Pipeline Market Segment Research Report 2022, which aims to sort out the development status and trends of the NASH Drug Pipeline industry at home and abroad, estimate the overall market scale of the NASH Drug Pipeline industry and the market share of major countries, analyze the development potential of each segment of the NASH Drug Pipeline industry, and study and judge the downstream market demand of NASH Drug Pipeline through systematic research, Analyze the competition pattern of NASH Drug Pipeline, so as to help solve the pain points of various stakeholders in NASH Drug Pipeline industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of NASH Drug Pipeline Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in NASH Drug Pipeline Market
Intercept
Genfit
Allergan
Madrigal
Immuron
Galectin
Gilead
89bio Inc
ABIONYX Pharma SA
Abivax SA
Abliva AB
Acquist Therapeutics
AdAlta Ltd
Afimmune Biopharma Ltd
Zhejiang Doer Biologics Corp
Dicerna Pharmaceuticals Inc
ChemomAb Ltd
DURECT Corp
Eli Lilly and Co
Enanta Pharmaceuticals Inc
EncuraGen Inc
Engitix Ltd
Heprotech Inc
Hinova Pharmaceuticals Inc
HK inno.N Corp
HotSpot Therapeutics Inc
Major Type of NASH Drug Pipeline Covered in XYZResearch report:
Protease Inhibitor
Immunomodulatory
Multiple Kinase Inhibitor
Application Segments Covered in XYZResearch Market
Clinical
Academic Research
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global NASH Drug Pipeline Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global NASH Drug Pipeline Market by Value
2.2.1 Global NASH Drug Pipeline Revenue by Type
2.2.2 Global NASH Drug Pipeline Market by Value (%)
2.3 Global NASH Drug Pipeline Market by Production
2.3.1 Global NASH Drug Pipeline Production by Type
2.3.2 Global NASH Drug Pipeline Market by Production (%)
3. The Major Driver of NASH Drug Pipeline Industry
3.1 Historical & Forecast Global NASH Drug Pipeline Demand
3.2 Largest Application for NASH Drug Pipeline (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional NASH Drug Pipeline Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of NASH Drug Pipeline Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US NASH Drug Pipeline Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe NASH Drug Pipeline Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China NASH Drug Pipeline Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan NASH Drug Pipeline Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India NASH Drug Pipeline Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea NASH Drug Pipeline Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia NASH Drug Pipeline Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global NASH Drug Pipeline Average Price Trend
12.1 Market Price for Each Type of NASH Drug Pipeline in US (2018-2022)
12.2 Market Price for Each Type of NASH Drug Pipeline in Europe (2018-2022)
12.3 Market Price for Each Type of NASH Drug Pipeline in China (2018-2022)
12.4 Market Price for Each Type of NASH Drug Pipeline in Japan (2018-2022)
12.5 Market Price for Each Type of NASH Drug Pipeline in India (2018-2022)
12.6 Market Price for Each Type of NASH Drug Pipeline in Korea (2018-2022)
12.7 Market Price for Each Type of NASH Drug Pipeline in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 NASH Drug Pipeline Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of NASH Drug Pipeline
14. NASH Drug Pipeline Competitive Landscape
14.1 Intercept
14.1.1 Intercept Company Profiles
14.1.2 Intercept Product Introduction
14.1.3 Intercept NASH Drug Pipeline Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Genfit
14.2.1 Genfit Company Profiles
14.2.2 Genfit Product Introduction
14.2.3 Genfit NASH Drug Pipeline Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Allergan
14.3.1 Allergan Company Profiles
14.3.2 Allergan Product Introduction
14.3.3 Allergan NASH Drug Pipeline Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Madrigal
14.4.1 Madrigal Company Profiles
14.4.2 Madrigal Product Introduction
14.4.3 Madrigal NASH Drug Pipeline Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Immuron
14.5.1 Immuron Company Profiles
14.5.2 Immuron Product Introduction
14.5.3 Immuron NASH Drug Pipeline Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Galectin
14.6.1 Galectin Company Profiles
14.6.2 Galectin Product Introduction
14.6.3 Galectin NASH Drug Pipeline Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Gilead
14.7.1 Gilead Company Profiles
14.7.2 Gilead Product Introduction
14.7.3 Gilead NASH Drug Pipeline Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 89bio Inc
14.8.1 89bio Inc Company Profiles
14.8.2 89bio Inc Product Introduction
14.8.3 89bio Inc NASH Drug Pipeline Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 ABIONYX Pharma SA
14.9.1 ABIONYX Pharma SA Company Profiles
14.9.2 ABIONYX Pharma SA Product Introduction
14.9.3 ABIONYX Pharma SA NASH Drug Pipeline Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Abivax SA
14.10.1 Abivax SA Company Profiles
14.10.2 Abivax SA Product Introduction
14.10.3 Abivax SA NASH Drug Pipeline Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Abliva AB
14.12 Acquist Therapeutics
14.13 AdAlta Ltd
14.14 Afimmune Biopharma Ltd
14.15 Zhejiang Doer Biologics Corp
14.16 Dicerna Pharmaceuticals Inc
14.17 ChemomAb Ltd
14.18 DURECT Corp
14.19 Eli Lilly and Co
14.20 Enanta Pharmaceuticals Inc
14.21 EncuraGen Inc
14.22 Engitix Ltd
14.23 Heprotech Inc
14.24 Hinova Pharmaceuticals Inc
14.25 HK inno.N Corp
14.26 HotSpot Therapeutics Inc
15. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
